Your browser doesn't support javascript.
loading
Red Marrow-Absorbed Dose for Non-Hodgkin Lymphoma Patients Treated with 177Lu-Lilotomab Satetraxetan, a Novel Anti-CD37 Antibody-Radionuclide Conjugate.
Blakkisrud, Johan; Løndalen, Ayca; Dahle, Jostein; Turner, Simon; Holte, Harald; Kolstad, Arne; Stokke, Caroline.
Afiliación
  • Blakkisrud J; Department of Diagnostic Physics, Oslo University Hospital, Oslo, Norway.
  • Løndalen A; Department of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway.
  • Dahle J; Nordic Nanovector ASA, Oslo, Norway.
  • Turner S; Nordic Nanovector ASA, Oslo, Norway.
  • Holte H; Department of Oncology, Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway; and.
  • Kolstad A; Department of Oncology, Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway; and.
  • Stokke C; Department of Diagnostic Physics, Oslo University Hospital, Oslo, Norway carsto@ous-hf.no.
J Nucl Med ; 58(1): 55-61, 2017 Jan.
Article en En | MEDLINE | ID: mdl-27587710
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Médula Ósea / Linfoma no Hodgkin / Tetraspaninas / Absorción de Radiación / Lutecio / Anticuerpos Monoclonales Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: J Nucl Med Año: 2017 Tipo del documento: Article País de afiliación: Noruega
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Médula Ósea / Linfoma no Hodgkin / Tetraspaninas / Absorción de Radiación / Lutecio / Anticuerpos Monoclonales Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: J Nucl Med Año: 2017 Tipo del documento: Article País de afiliación: Noruega